Mosanna Therapeutics Launches with $80 Million to Advance Novel Nighttime Nasal Spray for Obstructive Sleep Apnea
Link to full press release
Link to full press release
Link to full press release
Link to full press release
Link to full press release
Tom Needham Managing Director Longview Ventures Promotion
Link to full press release